VAXIGRIP TETRA Inactivated Quadrivalent Influenza Vaccine (Split Virion) influenza virus haemagglutinin 60 mcg 0.5 mL suspension Australia - English - Department of Health (Therapeutic Goods Administration)

vaxigrip tetra inactivated quadrivalent influenza vaccine (split virion) influenza virus haemagglutinin 60 mcg 0.5 ml suspension

sanofi-aventis australia pty ltd - influenza virus haemagglutinin, quantity: 15 microgram - injection, suspension - excipient ingredients: sodium chloride; water for injections; potassium chloride; monobasic potassium phosphate; dibasic sodium phosphate dihydrate - vaxigrip tetra is indicated for the prevention of influenza disease caused by the two influenza a virus subtypes and the two influenza b virus types contained in the vaccine for:,- active immunisation of adults, including pregnant women, and children from 6 months of age and older,- passive protection of infant(s) from birth to less than 6 months of age following vaccination of pregnant women (see sections 4.2 dose and method of administration, 4.4 special warnings and precautions for use, 4.6 fertility, pregnancy and lactation and 5.1 pharmacodynamic properties ? clinical trials).

VAXIGRIP TETRA Inactivated Quadrivalent Influenza Vaccine (Split Virion) influenza virus haemagglutinin 60 mcg 0.5 mL suspension for injection in pre-filled syringe needle free 2024 Season Australia - English - Department of Health (Therapeutic Goods Administration)

vaxigrip tetra inactivated quadrivalent influenza vaccine (split virion) influenza virus haemagglutinin 60 mcg 0.5 ml suspension for injection in pre-filled syringe needle free 2024 season

sanofi-aventis australia pty ltd - influenza virus haemagglutinin, quantity: 15 microgram - injection, suspension - excipient ingredients: sodium chloride; water for injections; potassium chloride; monobasic potassium phosphate; dibasic sodium phosphate dihydrate - vaxigrip tetra is indicated for the prevention of influenza disease caused by the two influenza a virus subtypes and the two influenza b virus types contained in the vaccine for:,- active immunisation of adults, including pregnant women, and children from 6 months of age and older,- passive protection of infant(s) from birth to less than 6 months of age following vaccination of pregnant women (see sections 4.2 dose and method of administration, 4.4 special warnings and precautions for use, 4.6 fertility, pregnancy and lactation and 5.1 pharmacodynamic properties ? clinical trials).

VIRUS PLUS- influenzinum, adenoviren nosode, herpes simplex 1, herpes simplex 2, cytomegalovirus nosode, epstein-barr virus noso United States - English - NLM (National Library of Medicine)

virus plus- influenzinum, adenoviren nosode, herpes simplex 1, herpes simplex 2, cytomegalovirus nosode, epstein-barr virus noso

deseret biologicals, inc. - influenza a virus (unii: r9hh0nde2e) (influenza a virus - unii:r9hh0nde2e), influenza b virus (unii: 1314jz2x6w) (influenza b virus - unii:1314jz2x6w), human adenovirus e serotype 4 strain cl-68578 (unii: fkd3duk39i) (human adenovirus e serotype 4 strain cl-68578 - unii:fkd3duk39i), human adenovirus b serotype 7 strain 55142 (unii: tm54l796sn) (human adenovirus b serotype 7 strain 55142 - unii:tm54l796sn), human herpesvirus 1 (unii: 22g38p19rl) (human herpesvirus 1 - unii:22g38p19rl), human herpesvirus 2 (u - for temporary relief of symptoms related to general viral infections (such as influenza, epstein-barr virus [ebv], cytomegalovirus [cmv], hepatitis, herpes, or adenovirus) including fever, fatigue, muscle aches and pain, rash, cold sores, swollen glands, headache and confusion. for temporary relief of symptoms related to general viral infections (such as influenza, epstein-barr virus [ebv], cytomegalovirus [cmv], hepatitis, herpes, or adenovirus) including fever, fatigue, muscle aches and pain, rash, cold sores, swollen glands, headache and confusion.

VIRUS COMBINATION (influenzinum- 2018-2019, adenoviren nosode, herpes simplex 1 nosode, herpes simplex 2 nosode, cytomegalovirus United States - English - NLM (National Library of Medicine)

virus combination (influenzinum- 2018-2019, adenoviren nosode, herpes simplex 1 nosode, herpes simplex 2 nosode, cytomegalovirus

deseret biologicals, inc. - influenza a virus a/singapore/gp1908/2015 ivr-180 (h1n1) antigen (formaldehyde inactivated) (unii: q3p251c5mt) (influenza a virus a/singapore/gp1908/2015 ivr-180 (h1n1) hemagglutinin antigen (formaldehyde inactivated) - unii:ld80h821hf), influenza a virus a/singapore/infimh-16-0019/2016 nib-104 (h3n2) antigen (formaldehyde inactivated) (unii: 2zsc17sij6) (influenza a virus a/singapore/infimh-16-0019/2016 nib-104 (h3n2) hemagglutinin antigen (formaldehyde inactivated) - unii:1r31m8u8h9), influenza b virus - for temporary relief of symptoms related to general viral infection (such as influenza, epstein-barr virus [ebv], cytomegalovirus [cmv], hepatitis, herpes, or adenovirus) including fever, fatigue, muscle aches and pain, rash, cold sores, headache and confusion.** **these statements are based upon traditional homeopathic principles. they have not been reviewed by the food and drug administration. for temporary relief of symptoms related to general viral infection (such as influenza, epstein-barr virus [ebv], cytomegalovirus [cmv], hepatitis, herpes, or adenovirus) including fever, fatigue, muscle aches and pain, rash, cold sores, headache and confusion.** **these statements are based upon traditional homeopathic principles. they have not been reviewed by the food and drug administration.

VIRUS PLUS (influenzinum- 2018-2019, adenoviren nosode, herpes simplex 1 nosode, herpes simplex 2 nosode, cytomegalovirus nosode United States - English - NLM (National Library of Medicine)

virus plus (influenzinum- 2018-2019, adenoviren nosode, herpes simplex 1 nosode, herpes simplex 2 nosode, cytomegalovirus nosode

deseret biologicals, inc. - influenza a virus a/singapore/gp1908/2015 ivr-180 (h1n1) antigen (formaldehyde inactivated) (unii: q3p251c5mt) (influenza a virus a/singapore/gp1908/2015 ivr-180 (h1n1) hemagglutinin antigen (formaldehyde inactivated) - unii:ld80h821hf), influenza a virus a/singapore/infimh-16-0019/2016 nib-104 (h3n2) antigen (formaldehyde inactivated) (unii: 2zsc17sij6) (influenza a virus a/singapore/infimh-16-0019/2016 nib-104 (h3n2) hemagglutinin antigen (formaldehyde inactivated) - unii:1r31m8u8h9), influenza b virus - for temporary relief of symptoms related to general viral infection (such as influenza, epstein-barr virus [ebv], cytomegalovirus [cmv], hepatitis, herpes, or adenovirus) including fever, fatigue, muscle aches and pain, rash, cold sores, headache and confusion.** **these statements are based upon traditional homeopathic principles. they have not been reviewed by the food and drug administration. for temporary relief of symptoms related to general viral infection (such as influenza, epstein-barr virus [ebv], cytomegalovirus [cmv], hepatitis, herpes, or adenovirus) including fever, fatigue, muscle aches and pain, rash, cold sores, headache and confusion.** **these statements are based upon traditional homeopathic principles. they have not been reviewed by the food and drug administration.

VIRUS COMBINATION (influenzinum- 2018-2019, adenoviren nosode, herpes simplex 1 nosode, herpes simplex 2 nosode, human herpesvir United States - English - NLM (National Library of Medicine)

virus combination (influenzinum- 2018-2019, adenoviren nosode, herpes simplex 1 nosode, herpes simplex 2 nosode, human herpesvir

deseret biologicals, inc. - influenza a virus a/singapore/gp1908/2015 ivr-180 (h1n1) antigen (formaldehyde inactivated) (unii: q3p251c5mt) (influenza a virus a/singapore/gp1908/2015 ivr-180 (h1n1) hemagglutinin antigen (formaldehyde inactivated) - unii:ld80h821hf), influenza a virus a/singapore/infimh-16-0019/2016 nib-104 (h3n2) antigen (formaldehyde inactivated) (unii: 2zsc17sij6) (influenza a virus a/singapore/infimh-16-0019/2016 nib-104 (h3n2) hemagglutinin antigen (formaldehyde inactivated) - unii:1r31m8u8h9), influenza b virus - for temporary relief of symptoms related to general viral infection (such as influenza, epstein-barr virus [ebv], cytomegalovirus [cmv], hepatitis, herpes, or adenovirus) including fever, fatigue, muscle aches and pain, rash, cold sores, headache and confusion.** **these statements are based upon traditional homeopathic principles. they have not been reviewed by the food and drug administration. for temporary relief of symptoms related to general viral infection (such as influenza, epstein-barr virus [ebv], cytomegalovirus [cmv], hepatitis, herpes, or adenovirus) including fever, fatigue, muscle aches and pain, rash, cold sores, headache and confusion.** **these statements are based upon traditional homeopathic principles. they have not been reviewed by the food and drug administration.

VIRUS COMBINATION (influenzinum- 2018-2019, herpes simplex 1 nosode, herpes simplex 2 nosode, human herpesvirus 6a, human herpes United States - English - NLM (National Library of Medicine)

virus combination (influenzinum- 2018-2019, herpes simplex 1 nosode, herpes simplex 2 nosode, human herpesvirus 6a, human herpes

deseret biologicals, inc. - influenza a virus a/singapore/gp1908/2015 ivr-180 (h1n1) antigen (formaldehyde inactivated) (unii: q3p251c5mt) (influenza a virus a/singapore/gp1908/2015 ivr-180 (h1n1) hemagglutinin antigen (formaldehyde inactivated) - unii:ld80h821hf), influenza a virus a/singapore/infimh-16-0019/2016 nib-104 (h3n2) antigen (formaldehyde inactivated) (unii: 2zsc17sij6) (influenza a virus a/singapore/infimh-16-0019/2016 nib-104 (h3n2) hemagglutinin antigen (formaldehyde inactivated) - unii:1r31m8u8h9), influenza b virus - for temporary relief of symptoms related to general viral infection (such as influenza, epstein-barr virus [ebv], cytomegalovirus [cmv], hepatitis, herpes, or adenovirus) including fever, fatigue, muscle aches and pain, rash, cold sores, headache and confusion.** **these statements are based upon traditional homeopathic principles. they have not been reviewed by the food and drug administration. for temporary relief of symptoms related to general viral infection (such as influenza, epstein-barr virus [ebv], cytomegalovirus [cmv], hepatitis, herpes, or adenovirus) including fever, fatigue, muscle aches and pain, rash, cold sores, headache and confusion.** **these statements are based upon traditional homeopathic principles. they have not been reviewed by the food and drug administration.

VIRUS COMBINATION (influenzinum- 2019-2020, herpes simplex 1 nosode, herpes simplex 2 nosode, human herpesvirus 6a, human herpes United States - English - NLM (National Library of Medicine)

virus combination (influenzinum- 2019-2020, herpes simplex 1 nosode, herpes simplex 2 nosode, human herpesvirus 6a, human herpes

deseret biologicals, inc. - influenza a virus a/brisbane/02/2018 ivr-190 (h1n1) antigen (formaldehyde inactivated) (unii: xw4jb03ti5) (influenza a virus a/brisbane/02/2018 ivr-190 (h1n1) hemagglutinin antigen (formaldehyde inactivated) - unii:92xe6ghc89), influenza a virus a/kansas/14/2017 x-327 (h3n2) antigen (formaldehyde inactivated) (unii: 3nzw5nd3d6) (influenza a virus a/kansas/14/2017 x-327 (h3n2) hemagglutinin antigen (formaldehyde inactivated) - unii:k329ycd1n9), influenza b virus b/maryland/15/2016 antigen (formaldehyde ina - for temporary relief of symptoms related to general viral infection (such as influenza, epstein-barr virus [ebv], cytomegalovirus [cmv], hepatitis, herpes, or adenovirus) including fever, fatigue, muscle aches and pain, rash, cold sores, headache and confusion.** **these statements are based upon traditional homeopathic principles. they have not been reviewed by the food and drug administration. for temporary relief of symptoms related to general viral infection (such as influenza, epstein-barr virus [ebv], cytomegalovirus [cmv], hepatitis, herpes, or adenovirus) including fever, fatigue, muscle aches and pain, rash, cold sores, headache and confusion.** **these statements are based upon traditional homeopathic principles. they have not been reviewed by the food and drug administration.

DENGVAXIA POLVO Y DISOLVENTE PARA SUSPENSIÓN INYECTABLE MULTIDOSIS (VACUNA TETRAVALENTE CONTRA EL DENGUE DE VIRUS ATENUADOS) Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

dengvaxia polvo y disolvente para suspensión inyectable multidosis (vacuna tetravalente contra el dengue de virus atenuados)

sanofi pasteur - virus cyd del dengue serotipo 1 - virus cyd del dengue serotipo 1....4,5-6 log10 ccid50/dosisi / virus cyd del dengue serotipo 2 ....4,5-6 log10 ccid50/dosisi / virus cyd del dengue serotipo 3....4,5-6 log10 ccid50/dosisi / virus cyd del dengue serotipo 4....4,5-6 log10 ccid50/dosisi / cloruro de sodio....0.9%

DENGVAXIA POLVO Y DISOLVENTE PARA SUSPENSIÓN INYECTABLE UNIDOSIS (VACUNA TETRAVALENTE CONTRA EL DENGUE DE VIRUS ATENUADOS) Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

dengvaxia polvo y disolvente para suspensión inyectable unidosis (vacuna tetravalente contra el dengue de virus atenuados)

sanofi pasteur - virus cyd del dengue serotipo 1 - virus cyd del dengue serotipo 1....4,5-6 log10 ccid50/dosisi / virus cyd del dengue serotipo 2 ....4,5-6 log10 ccid50/dosisi / virus cyd del dengue serotipo 3....4,5-6 log10 ccid50/dosisi / virus cyd del dengue serotipo 4....4,5-6 log10 ccid50/dosisi / cloruro de sodio....2 mg